Galderma Group AG
Galderma Group AG is a Switzerland-based company in the Healthcare sector with a market capitalisation of $49.8B. Its FinScore is 69/100; its highest-scoring layer is Momentum (81) and its lowest is Value (32). The shares trade at 58.1x trailing earnings and are up 10% year to date.
Share price performance
About Galderma Group AG
www.galderma.comGalderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- Switzerland
- Fiscal year-end
- December
- Trading currency
- CHF
- Reporting currency
- USD
- Fundamentals updated
- 87 days ago
- Market cap
- $49.8B
- Shares outstanding
- 233.2M
- P/E (TTM)
- 58.1x
- Dividend yield (TTM)
- 0.20%
- Beta (issuer)
- -0.10
- Revenue (latest FY)
- $5.2B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for Galderma Group AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Galderma Group AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Galderma Group AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Galderma Group AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Galderma Group AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Galderma Group AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.